We also determined the expression of cadherins relative to EMT.
ELISA and RT-PCR determined the expression of IL-l2.
Next, we determined the expression of phosphor-NFκB, NFκB, phosphor-IκB, and IκB in LPS-stimulated peritoneal macrophages.
To further investigate these observations, we determined the expression of RRM1, RRM2 and P53R2 using the Western blot.
We also determined the expression levels of Nicotinamide mononucleotide adenylyltransferase 2 (Nicotinamideotinamide phosphoribosyltransferase (NAMPT), Sirtuin 1 and 3 (SIRT1, 3), and Poly [ADP-ribose] polymerase 1 (PARP1) (Fig. 6b).
Using quantitative PCR, we determined the expression of chinmo, and some computationally predicted targets of miR-125 and miR-100, as there are no experimentally validated miRNA/mRNA interactions for these two miRNAs.
We also determined the expression levels of EscJ, which is a structural component of the T3SS apparatus, and of the effector protein Tir, which is expected to be retained within the bacterial cells in the absence of host cells.
In this study, we determined the expression pattern of SFRP2 and disclosed its influence on WNT16B-associated cancer activities, exemplifying the complex dynamics of soluble factors in the TME where cancer cells are subject to treatment selection pressure.
To investigate the role played by individual BET bromodomain proteins in myogenic differentiation, we determined the expression profile of BET proteins in C2C12 cells at various time points during the transition from myoblasts to myotubes.
In the current study, we determined the expression levels of the CRBN-binding proteins IKZF1, IKZF3, and KPNA2 in MM cells in a cohort of 214 patients with newly diagnosed MM before treatment with an induction therapy containing lenalidomide.
We first determined the expression patterns of CDK6 in osteosarcoma tissues.
